OneMedNet Corporation (ONMD) Stock Price & Analysis
OneMedNet Corporation (ONMD) — MoonshotScore 21/100 (Weak band), calculated Nov 18, 2026. Price $4.70 (+4.21%), as of the Nov 20, 2026 trading session; market cap $29.2M.
Educational signal · not a buy or sell recommendation · How to read this
OneMedNet Corporation · ONMD · NASDAQ
OneMedNet Corporation offers clinical imaging solutions through its iRWD platform, leveraging AI for data de-identification and curation. The company partners with medical and academic institutions to advance medical research and diagnostics.
Price as of Nov 20, 2026
Key Statistics
MoonshotScore v2 · OneMedNet (ONMD)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Bottom-tier quality, a fragile balance sheet, weak growth and a full valuation. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Strained; Valuation: Full; Growth Durability: Fading; Momentum: Slipping.
- quarterly revenue $177,000 (Q3 FY2025, quarter ended Sep 2025)
Holding back: weak fundamentals, balance-sheet strain, soft growth, weak price trend
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 21 | Weak | |
| 21 | Weak | |
| 21 | Weak | |
| 21 | Weak | |
| 21 | Weak | |
| 21 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $4.70 | |
| Change on the day | +4.21% | |
| Market capitalisation | $29.2M | — |
| Shares traded on the day | 8.3K |
Price & events
Other perspectives
Council score for OneMedNet (ONMD): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
Two of these lenses read this company more favourably than the MoonshotScore does: Englander-style lens and Moon AI lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
On Nov 19, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is OneMedNet (ONMD), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. OneMedNet Corporation (ONMD) is listed on NASDAQ. It employs 22 people. In Q3 FY2025 it reported revenue of $177,000 and net income of -$741,000. The market values it at $29.2M.
What do the latest results show for OneMedNet (ONMD)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $177,000.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $177,000 | -$741,000 | -$0.14 (diluted) |
| Q4 FY2025 | $891,000 | -$3M | — |
| Q1 FY2026 | $96,000 | -$2M | -$0.44 (diluted) |
| Q2 FY2026 | $292,000 | -$2M | -$0.37 (diluted) |
What are the financial strengths and risks for OneMedNet (ONMD)?
Short answer
What is holding it back is weak fundamentals, balance-sheet strain, soft growth, weak price trend. The distress and quality screens read Piotroski F 4. Trailing ratios: current ratio 0.38.
How is OneMedNet scored?
Short answer · as of
A same-model peer rank is unavailable in the current peer set. The MoonshotScore combines business quality, financial safety, valuation, growth durability and momentum; open “Why this rating?” for the method and drivers.
The records behind this page
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 9, 2026
- Transactions
- 17
- Identified insiders
- 4
- Purchases
- 10
- Sales
- 5
- Other transactions
- 2
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ONMD in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ONMD in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about OneMedNet (ONMD)?
Investor Questions: ONMD Stock
These answers are editorial: 1 of these 9 answers is drawn from the ONMD research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for ONMD?
ONMD carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. OneMedNet Corporation offers clinical imaging solutions through its iRWD platform, leveraging AI for data de-identification and curation.
Is ONMD a good stock to buy?
Stock Expert AI does not rate ONMD buy, sell or hold. OneMedNet Corporation carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the ONMD stock price today?
The last price recorded for OneMedNet Corporation (ONMD), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for ONMD?
OneMedNet Corporation faces several key risks. The company's negative profit and gross margins raise concerns about its financial sustainability. Competition from larger, more established players in the healthcare IT space poses a significant challenge.
What are the key factors to evaluate for ONMD?
OneMedNet Corporation (ONMD) holds a MoonshotScore in the low range. iRWD platform utilizes AI to de-identify and curate imaging data. Not financial advice.
How frequently does ONMD data refresh on this page?
ONMD's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven ONMD's recent stock price performance?
OneMedNet Corporation (ONMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary iRWD platform with AI capabilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ONMD overvalued or undervalued right now?
OneMedNet Corporation (ONMD) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of ONMD?
Fractional-share availability for OneMedNet Corporation (ONMD) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com